Background: Transient ischemic attacks are common and place patients at risk of subsequent stroke. The 2007 EXPRESS and SOS-TIA studies demonstrated the efficacy of rapid treatment initiation. We hypothesized that with these findings having informed subsequent transient ischemic attacks management protocols, transient ischemic attacks prognosis in contemporary (2008 and later) patient cohorts would be more favorable than in historical cohorts.
Introduction
Transient ischemic attacks (TIAs) are common and place patients at risk of subsequent stroke. 1 Given the considerable potential for mortality and serious morbidity related to stroke, the risk of stroke following TIA is a major health issue. In contemporary practice, with emerging diagnostic techniques and with revised guidelines incorporating evidence for rapid management policies and use of risk stratification strategies, TIA can be diagnosed and managed early. Landmark studies (EXPRESS and SOS-TIA) 1 ,2 demonstrated that urgent evaluation and commencement of therapy markedly reduce the risk of stroke. With implementation of these findings in clinical practice, it may be expected that TIA prognosis in patients engaging with contemporary health care systems would be more favorable than in historical cohorts. We sought to test this hypothesis.
Methods
We conducted a systematic review of prospective and retrospective cohort studies (hospital-based and community-based cohorts) of TIA, plus placebo-arms of randomized controlled trials (RCTs). We defined contemporary practice as practice reported in studies published in the post-EXPRESS/SOS-TIA (post-2007) era. Thus, we included studies published from 2008 to 2015. The outcomes of interest were stroke, recurrent TIA, myocardial infarction, and mortality.
Search strategy and screening process
The search was conducted using the electronic databases: Ovid Medline, Cochrane Library, and Embase. Duplicate results of the search were removed and abstracts were screened and assessed for eligibility. Following screening of abstracts, full-text copies of potentially eligible papers were retrieved and assessed for eligibility. The abstracts, methods, and outcomes for each study were assessed for eligibility separately by two researchers (NN and PM) and any cases of disagreement were adjudicated by a third researcher (CL).
Reference studies of included papers were searched for relevant studies. Papers published prior to 2008 were excluded. While acknowledging that papers published later than 2007 may still include patients recruited prior to 2007, this provided an identifiable marker of (post-EXPRESS/SOS-TIA) contemporary TIA practice.
Inclusion criteria. Prospective and retrospective cohort studies (hospital-based and community-based cohorts) of TIA were included. In addition to this, placebo-arms of randomized control trials were also included. The study factor was TIA, and so studies of stroke and TIA were included only if TIA was reported separately. The primary outcome factor was stroke and secondary outcome factors were recurrent TIA, myocardial infarction, and death. Studies reporting these outcomes were included. We included in the systematic review all studies of TIA even if the entry criteria for the studies were restricted (e.g. only patients with atrial fibrillation (AF)). However, we restricted our meta-analysis to studies with no restriction on the type of TIA patients.
Exclusion criteria. Studies with outcomes only at timepoints less than 48 h post-TIA were not included in the systematic review. We excluded studies of both stroke and TIA, if the outcome of TIA patients was not reported separately.
For the meta-analysis, studies which included (on the basis of study population selection) only higher risk or only lower risk patient populations were excluded. These excluded studies were: those which defined TIA according to the tissue-based definition rather than the traditional World Health Organization (WHO) time-based definition, studies which excluded AF patients, studies which included only patients undergoing carotid endarterectomy (CEA), and studies which had a restricted patient age group.
TIA definition: The definition of TIA was by each individual study (either standard WHO definition or tissue-based definition).
Outcome definition: The primary outcome of interest was stroke and we accepted each study's stroke definition. Similarly, we accepted each study's definition of secondary outcomes of myocardial infarction and death.
The meta-analysis was performed only with stroke as the outcome factor.
Data extraction
The PRISMA 2009 criteria were followed. In studies including patients with both TIA and stroke, with the outcome for TIA patients not reported separately, the corresponding author was contacted and specific TIA data were requested.
Extracted information from each article included: title, author, publication year, journal, period of data collection, source of TIA diagnosis (e.g. emergency department (ED) physician, neurologist), definition of TIA (WHO time-based or tissue-based definition), country/countries where the study was conducted, study population (e.g. ED, hospital in-patient), study participant limitations (e.g. gender), clinical limitations (e.g. carotid stenosis, AF), number of TIA participants at baseline, number of TIA participants analyzed, study outcomes (in addition to stroke), method of outcome ascertainment, type of study (prospective/retrospective cohort, RCT), duration of follow-up, and results (stroke, mortality, TIA, and Myocardial Infarction (MI)). Data extraction was independently performed by two researchers (NN, PM, and CGE). Any cases of disagreement were adjudicated by a third researcher (CL).
International Journal of Stroke, 14 (5) Statistical analysis Meta-analysis. We conducted a meta-analysis of 40 studies (33 prospective studies, 7 retrospective studies) with outcome factor stroke. The time-points of interest for cumulative risk of stroke recurrence are at 2, 7, 30, and 90 days post-TIA. We aimed to estimate the pooled cumulative risk of stroke recurrence at each time-point.
A standard meta-analysis of the risk at each timepoint is problematic since the same studies do not contribute data at each possible time-point; as such, estimates of the pooled cumulative risk at each timepoint are not guaranteed to be non-decreasing since the within-study correlation of estimates are ignored. We utilize a model for the multivariate (joint) analysis of all studies at every available time-point. In this approach, information is borrowed from studies that contribute to multiple time-points, improving the precision of the estimates, and the cumulative probabilities of stroke are explicitly constrained to be non-decreasing. We have utilized the Bayesian model presented in Jackson et al. 3 Briefly, the probability of stroke at each study for each period is modeled on the log-odds scale to be the sum of the unconditional log-odds of stroke at each time-point (averaged across sites) and a study specific random effect (to model between study heterogeneity), assumed to follow a multivariate normal distribution. The unconditional probability of stroke at each timepoint (averaged across sites) is the parameter of interest, reflecting the pooled cumulative risk at each time-point. To complete the Bayesian model, uninformative prior distributions were placed on all model parameters; a Wishart prior was used for the covariance matrix of the random effect, and normal distributions (zero mean and variance of 1000) were used for the four time-specific unconditional log-odds parameters.
Bayesian inference was implemented via Markov Chain Monte Carlo (MCMC) simulation using the WinBUGS software 4 where we took 500,000 simulations from the posterior joint distribution, allowing for a burn-in period of 50,000 simulations. Pooled cumulative stroke risks are summarized from the posterior distribution as the mean with 95% credible intervals given as the 2.5 and 97.5 percentiles. Convergence was assessed through inspecting trace plots of the MCMC simulated values and running two MCMC chains to assess convergence using the Gelman-Rubin diagnostics. Data manipulation, summarizing, and graphing were performed using R V3.3 software. 5 
Results

Study selection
Databases searching yielded a total of 4304 publications. After excluding duplicate records and screening, 130 full-text articles were retrieved and assessed for eligibility. Eighty-three of these studies were excluded. Five RCT placebo-arms met our inclusion criteria but were not included as the authors did not respond to our request for additional data. The remaining 47 studies met the inclusion criteria and were included in the systematic review. We included 40 studies in the metaanalysis. See Figure 1 for the PRIMA flow diagram.
Systematic review
Characteristics of studies/data. Forty-seven studies (N ¼ 191,202 patients) were included in the systematic review. The study characteristics are summarized in the online Supplementary Table 1 . In all 47 studies, the patients had a TIA as an index event at baseline.
Diagnosis. The diagnostic criteria for TIA were the timebased WHO definition (32/47 (68.1%) of the studies) or tissue-based definition (3/47 (6.4%) of the studies). In 12/47 (25.5%) of studies, TIA definition was not reported. We assumed a standard WHO time-based definition in these studies. In 25/47 (53.2%) of studies, the TIA diagnosis was made by a neurologist. ED physicians and stroke physicians made the diagnosis in 6/47 (12.8%) and 3/47 (6.4%) of studies, respectively. In 1/47 (2.1%) of studies, a physician made the diagnosis. Vascular neurologists made the diagnosis in 2/47 (4.3%) of studies. In 10/47 (21.3%) of studies, it was not reported who made the diagnosis.
Study population. The admission criteria and patient population were also different among studies. In 19/47 (40.4%) of studies, the study population were non-selected ED care/all comers. Hospital in-patient admission with a clear admission policy (study participant limitations such as age, gender, magnetic resonance imaging/magnetic resonance angiography (MRI/MRA) on admission, carotid stenosis, and admission within either 24 h or 48 h of symptom onset) accounted for 8/47 (17%) of studies, whereas 9/47 (19.1%) of studies included in-patient hospital admissions but without a clear admission policy or with admission policy not stated. In 2/47 (4.3%) of the studies, the patients referred to a stroke clinic were included in the study and 2/47 (4.3%) of the studies had patients from a TIA clinic. In 2/47 (4.3%) of studies, included patients were from ED (attended by neurologist) and there were 2/47 (4.3%) community studies. In 2/47 (4.3%) of the studies, the location of the study population was not reported and 1/47 (2.1%) of the studies had an unclear study population. 
Meta-analysis
The 40 studies included 68,563 patients. The MCMC chains from the Bayesian multivariate meta-analysis model appeared to converge to stable distributions after excluding the first 50,000 simulations, and summaries of the posterior distributions for cumulative risks at each time-point are provided in Table 1 . The study specific stroke risks at each time-point are plotted together with estimates of the pooled risks in Figure 2 , where each dot represents an individual study.
Discussion
Summary of main findings
The systematic review displayed variability in definition of TIA and clinical status of a person making the diagnosis of TIA. A few studies had markedly restricted study populations. While there were differences in study populations' location of care and service model between studies, the participants were almost all managed in secondary care rather than primary care. 
Comparison with previous studies (pre-EXPRESS/ SOS-TIA)
The early Oxfordshire study (1981) (1982) (1983) (1984) (1985) (1986) ) reported stroke risk of 8.6% at 7 days and 12.0% at 30 days post-TIA. 6 The Greater Cincinnati/Northern Kentucky Stroke Study (1993) (1994) reported stroke risk of 14.6% after TIA. 7 The California study (1997) (1998) , reported 90-day stroke risk of 10.5%. 8 A Canadian study (1999) (2000) reported 90-day stroke risk of 9.5%. 9 In Northern Portugal (1998-2000), the 7-day stroke risk was found to be 12.8%. 10 A small number of pre-EXPRESS studies reported stroke risk equivalent to, or less than in, our metaanalysis. An ED-based study in Canada (in 2000) reported 30-day stroke risk of 5%. 11 In another study conducted in France (2003-2005) , of patients admitted to the stroke unit, the stroke risk at 1 week and 3 months was found to be 2.5% and 3.5%, respectively.
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A systematic review and meta-analysis published in 2007, however, found stroke risk of 3.1% at 2 days (compared to 1.2% in our meta-analysis) and 5.2% at 7 days (compared to 3.4% in our meta-analysis), and lowest risks were seen among patients treated in specialist stroke services. 13 Thus, recurrent stroke risk in these ''pre-EXPRESS/ pre-SOS-TIA'' studies was generally greater than (often considerably greater than) the stroke-risk in our metaanalysis.
Stroke risks in our meta-analysis were greater than in SOS-TIA and in ''phase 2'' of EXPRESS. In SOS-TIA (2003) (2004) (2005) , 90-day stroke risk was 1.24%. 2 In EXPRESS (2004-2007) , the 90-day stroke risk decreased from 10.3% in phase 1 to 2.1% in phase 2.
1 Stroke risk in our meta-analysis was also greater than in a large study reported subsequent to our review and meta-analysis (see below). 14 
Interpretation of the findings
We have found that, compared to findings in pre-EXPRESS historical cohorts, our meta-analysis of studies in more contemporary health settings reported lower rates of stroke following a TIA.
In ''optimal'' contemporary practice, Amarenco et al.'s recent multi-site study (2009-2011) published in 2016 (subsequent to our review) found that stroke rates following a TIA or minor stroke at 2, 7, 30, and 90 days were 1.5%, 2.1%, 2.8%, and 3.7%, respectively, 14 that is, lower rates than in our meta-analysis. This study was conducted (like EXPRESS and SOS-TIA) in highly specialized settings where urgent evaluation and management of TIA were implemented via protocols in accordance with evidence-based best practice care.
Thus, we have demonstrated a gradient of highest stroke risk post-TIA in findings from ''historical'' cohorts (highest risk), to the findings of ''post-EXPRESS'' cohorts included in our meta-analysis, to the findings of a ''contemporary best-practice'' cohort (lowest risk).
The defining characteristics of clinical practice (reflected in evidence-based clinical guidelines) [15] [16] [17] contemporaneous with this gradient in findings is, decreasing time from incident event to initiation of management. Treatment modalities were largely unchanged.
Strengths and limitations
Strengths. A strength of this systematic review and metaanalysis is the large number of studies from across a wide range of (secondary care) health care settings from around the world. In the 47 studies included in the systematic review, there were 191,202 patients, with 68,563 patients included in the meta-analysis.
Limitations. An important limitation is a time lag in introduction of system change in TIA care, data collection, and publication. Our sample population of studies included some patients who received treatment before the EXPRESS/S0S-TIA studies' publication (i.e. pre-2007). This together with different patient population and different health systems' approaches (not always informed by EXPRESS/SOS-TIA findings) makes our sample population highly heterogeneous. Hence, an appreciable proportion of patients in our systematic review and meta-analysis would not have received what is considered optimal care post-EXPRESS/SOS-TIA. This, however, would have biased our findings towards the null, i.e. less difference in stroke-rates between historical and post-EXPESS studies. Our results remain robust from this viewpoint.
Secondly, there is a difference in ascertainment of study factor (TIA) in different studies. The case ascertainment method varied across studies. Most studies diagnosed TIA as per the time-based WHO definition while some studies followed the tissue-based definition. Studies explicitly employing tissue-based definition of TIA, however, were excluded from our meta-analysis.
Additionally, there was heterogeneity in clinicians making the diagnosis of TIA, ranging from stroke physicians to ED physicians to ED residents. 18 Given the frequent difficulty of TIA diagnosis, there is International Journal of Stroke, 14(5) potential for differences in diagnostic accuracy between included studies. 19 
Implications for practice and policy
A consideration of our findings in the context of previous literature and changes in evidence-based clinical guidelines suggests that the poorer prognosis in historical population contrasted with findings of more contemporary populations may be due to TIA patients being treated less intensely in historical cohorts. Furthermore, the results of the study conducted in expert tertiary stroke care centres and published in 2016 14 suggest that with closer adherence to contemporary best practice, even better prognosis of TIA can be achieved. This difference suggests that clinical expertise and/or systems of care continue to be important factors in TIA outcomes in contemporary practice.
Implementation of best evidence TIA management requires organized systems of care. Although many hospitals in many countries have stroke units and acute neurovascular clinics, equipped with modern diagnostic facilities and specialist staff to provide optimal care, delays in seeking medical help, and delays in management will likely be continuing to have a negative impact on TIA outcomes even in such systems. 20 It is important that patients understand the symptoms of TIA and the health practices make a correct diagnosis and initiate treatment urgently.
Implications for further research
The processes of care and outcomes of TIA patients can be improved by having optimal infrastructure. In many settings, such a highly specialized care system with specialized personnel and availability of advanced technologies, outside of a research setting is not feasible. 21 Prehospital care after a TIA plays an important role in primary health care settings. Managing TIA patients effectively in primary health care settings is of prime importance, as most of the patients seek initial help from their primary care physicians. General practitioners (GPs) have a role in managing TIA. 21 Systems delays, however, can result in many patients presenting to GPs not receiving appropriate care within guidelinebenchmarked timeframes. 21, 22 Future research could evaluate models of integrated GP-specialist care utilizing, for example, telemedicine (which has proven effective in acute stroke care).
Conclusion
We hypothesized that the prognosis of TIA patients in studies reported in the years post-2007 will be improved compared to studies reported prior to 2008. We found that the prognosis of TIA patients is more favorable in the modern health care settings. This may reflect improvements in service models for TIA patients' care, with research evidence being translated promptly (though not always completely) into clinical practice.
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